Journal of the American Society of Nephrology

Founded in 1966, the American Society of Nephrology (ASN) is the world’s largest professional society devoted to the study of kidney disease. Composed of 11,000 physicians and scientists, ASN promotes expert patient care, advances medical research, and educates the renal community. ASN also informs policymakers about issues of importance to kidney doctors and their patients. Each year, ASN provides nearly 500 research and travel grants. ASN annual meetings are attended by 14,000 physicians and researchers, and regional meetings are held throughout the year. The society publishes the Journal of the American Society of Nephrology (JASN) (impact factor 7.111), the Clinical Journal of the American Society of Nephrology, the Nephrology Self-Assessment Program (NephSAP), ASN Kidney News, and Kidney Daily. JASN, established in 1990, publishes original articles of the highest quality that are relevant to the broad field of nephrology. CJASN, whose inaugural issue was in January 2006, is a journal dedicated to advancing the practice of renal medicine by reporting novel and rigorous clinical research.

American Society of Nephrology
Impact factor
7.111 ()

Some content from Wikipedia, licensed under CC BY-SA

Medical research

Predicting the success of kidney transplantations

It may not receive the same attention as the heart or brain, but a diseased kidney can be more deadly, with effects that weaken the heart, bones, and immune system, let alone the kidney itself. End-stage kidney disease has ...

Diseases, Conditions, Syndromes

Protection of dialysis patients from COVID variants of concern

Researchers led by the Marien Hospital Herne, a Ruhr-Universität Bochum clinic, have investigated the extent to which mRNA vaccines protect dialysis patients from infection with variants of concerns of SARS-Cov-2. They showed ...

Diseases, Conditions, Syndromes

For dialysis recipients, antibody response lowest with Ad26.COV2.S

(HealthDay)—For patients receiving dialysis who are fully vaccinated against COVID-19, the prevalence of no or diminished response varies by vaccine type and is higher with the attenuated adenovirus Ad26.COV2.S vaccine, ...

page 1 from 35